Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about TEVA PHARMACEUTICAL INDUST
05:04pTEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Two Strengths of ..
BU
02/16BERKSHIRE HATHAWAY : Cramer shocked by Buffett's investment in "second-rate" Tev..
AQ
02/16Backstory - Warren Buffett's Valentine's Day surprise for investors
RE
02/16WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
RE
02/16BACKSTORY : Warren Buffett's Valentine's Day surprise for investors
RE
02/15Cisco Systems and Teva jump while NetApp slumps
AQ
02/15TEVA PHARMACEUTICAL INDUSTRIES : closing Netanya plant, laying off 220
AQ
02/15Teva Spikes on Berkshire Stake
AQ
02/15Teva jumps on Berkshire Hathaway investment
AQ
02/14TEVA PHARMACEUTICAL INDUSTRIES : Announces U.S. Launch of QVAR RediHaler Inhalat..
AQ
02/13TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of a Generic Version of Syprin..
AQ
02/13Novartis gains U.S. approval for delayed MS drug
RE
02/12TEVA PHARMACEUTICAL INDUSTRIES : Announces U.S. Launch of QVAR® RediHaler™..
BU
02/09MADRIGAL PHARMACEUTICALS : Here’s What’s Moving Teva Pharmaceutical ..
AQ
02/09TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of a Generic Version of Syprin..
BU
More most relevant news
All news about TEVA PHARMACEUTICAL INDUST
05:04pTEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Two Strengths of ..
BU
02/16BERKSHIRE HATHAWAY : Cramer shocked by Buffett's investment in "second-rate" Tev..
AQ
02/16NOVARTIS : FDA Approves Another New Generic Form of 40mg Copaxone
AQ
02/16Backstory - Warren Buffett's Valentine's Day surprise for investors
RE
02/16WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
RE
02/16BACKSTORY : Warren Buffett's Valentine's Day surprise for investors
RE
02/15Cisco Systems and Teva jump while NetApp slumps
AQ
02/15TEVA PHARMACEUTICAL INDUSTRIES : closing Netanya plant, laying off 220
AQ
02/15TEVA PHARMACEUTICAL INDUSTRIES : Reports 2017 Full Year and Fourth Quarter Finan..
AQ
02/15Teva Spikes on Berkshire Stake
AQ
More news
Sector news : Pharmaceuticals - NEC
12:41pMERCK : and Partners Start EUR20 Million Israel Biotech Fund
DJ
02/19BASF to face millions in extra costs in UK each year from Brexit - Handelsbla..
RE
02/19UK shares retreat as Reckitt disappoint
RE
02/19Reckitt shares sink on missed profit, vague outlook
RE
02/19NOVARTIS : Correction to Novartis CEO story
DJ
02/19Stronger European Earnings Augur More M&A, Higher Dividends
DJ
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
04:33aTracking John Paulson's Paulson & Company Portfolio - Q4 2017 Update 
02/19Warren Buffett's Berkshire Claims $358 Million Investment In Teva, But That D.. 
02/19VALEANT : Generic Syprine Is Finally Here 
02/19MARKET ROVER : 20 High-Yield Bonds Selling Off, These 3 Are Worth Considering 
02/19TEVA : Berkshire Is Barking Up The Wrong Tree 
02/18You May Not Want To Follow Buffett Out Of Phillips 66 
Latest Tweets
05:13pTeva Announces Exclusive Launch of Two Strengths of a Generic Version of Solo.. 
10:56aTeva Pharmaceutical Industries Ltd $TEVA Stake Decreased by Barrow Hanley Mew.. 
02:34aZacks: Brokerages Expect Teva Pharmaceutical Industries Ltd $TEVA Will Post Q.. 
02/18Teva Pharmaceutical Industries Ltd $TEVA Stake Lessened by Schroder Investmen.. 
02/18Sigma Planning Corp Acquires Shares of 11,305 Teva Pharmaceutical Industries .. 
More tweets
Qtime:47
Financials ($)
Sales 2018 19 600 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 1,05x
Capi. / Sales 2019 1,06x
Capitalization 20 599 M
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 18,5 $
Spread / Average Target -9,9%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED15.92%20 599
JOHNSON & JOHNSON-7.19%357 710
NOVARTIS-3.37%224 785
PFIZER-2.84%216 135
ROCHE HOLDING LTD.-9.37%207 160
MERCK AND COMPANY-0.50%153 359